CPHI
CHINA PHARMA HOLDINGS, INC.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- E Jul 21 Trading halt: Halt Resumed: CPHI — trading resumed after M (Volatility T…
- E Jul 22 Trading halt: Halt Resumed: CPHI — trading resumed after M (Volatility T…
- E Jul 22 Trading halt: Trading Halt: CPHI — M (Volatility Trading Pause)
- R Jul 23 China Pharma Holdings is conducting a deeply dilutive offering of 2.…
- X Jul 31 Short interest falls 72.0% to 115.7K
- X Aug 14 Short interest jumps 439.3% to 623.8K
- X Aug 31 Short interest falls 68.6% to 195.8K
- X Sep 30 Short interest falls 66.1% to 61.9K
Signal stack
Where each data set points today.
- InstitutionsBULLISH
Q2 2026: 3 added (0 new), 0 trimmed or exited.
- TrendRANGE
18% below its 50-day average.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| CITADEL ADVISORS LLC | DOUBLED | $82.8K |
| RENAISSANCE TECHNOLOGIES LLC | ADD | $9.9K |
| UBS Group AG | DOUBLED | $2.1K |
| UBS Group AG | NEAR_EXIT | $621.00 |
| CITADEL ADVISORS LLC | ADD | $59.3K |
| UBS Group AG | TRIM | $37.4K |
| UBS Group AG | DOUBLED | $27.5K |
Quarterly 13F filings are due 45 days after each quarter ends.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Oct 15, 2026| Jul 22, 2026 | Volatility Pause | Resumed |
| Jul 21, 2026 | Volatility Pause | Resumed |
| Jul 21, 2026 | Volatility Pause | Resumed |
| Jul 21, 2026 | Volatility Pause | Resumed |
| Jul 21, 2026 | Volatility Pause | Resumed |
SecBot reports
2 filings · 0 bullish · 1 bearish · 1 neutral- BEARISH 424B5Jul 23, 2026
China Pharma Holdings is conducting a deeply dilutive offering of 2.5M shares at $2.00/share — a…
The extreme discount to market and small cash balance suggest urgent financing needs. Expect near-term downward pressure as the discounted shares hit the market. The 90-day lock-up on insiders…
- NEUTRAL 8-KJul 22, 2026
China Pharma Holdings priced a registered direct offering of 2.5 million shares at $2.00 per share…
The offering provides a modest cash infusion for working capital but creates ~1.5% dilution. Monitor the company's next quarterly filing for any change in operating trends or cash burn rate. The…
All CPHI filing & press-release reports (2)
- 424B5 reportJul 23, 2026
- 8-K reportJul 22, 2026